Aeglea BioTherapeutics, Inc. Purchase Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated July 27, 2023, by and between the Company and Immedica Pharma AB
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated December 7, 2023, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated as of December 7, 2023, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc. and Immedica Pharma AB
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated June 22, 2023, by and among the Registrant and the purchasers named therein
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc. and Immedica Pharma AB
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated as of June 22, 2023, by and among Aeglea BioTherapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Securities Purchase Agreement, dated as of May 5, 2022, by and among Aeglea BioTherapeutics, Inc. and the purchasers identified therein
Purchase Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2022